Thanks for your question, Alina. The straight answer is "No". For two reasons. First, and very subjectively, I have had a life-long aversion to drugs (the mind-altering ones) and therefore, they don't play much of a role in my work. Of course, microdosing is another ballgame altogether, but so far, the micro-dosing experiments, in general, have not supplied convincing evidence for tangible health effects. Second, for ibogaine, the evidence is even less clear, because of the drug's known cardiotoxicity. That's what has stifled research into it. However, there was a trial on U.S. Special Operations Veterans, which showed some measurable cognitive benefits. But this trial wasn't about dementia it was about the fallouts of PTSD and traumatic brain injury. So, I really can't make a "mortgageable" comment on it.